Inclusion criteria were primary HIV-@ infection ( an incomplete HIV-@ western blot and detectable plasma HIV-RNA ) , with either symptoms or a CD@ + cell count below @ cells per L. Patients were randomly assigned ( @:@ ) to an intensive , five-drug cART regimen ( raltegravir @ mg and maraviroc @ mg twice daily , and a fixed-dose combination of tenofovir disoproxil fumarate @ g plus emtricitabine @ g , darunavir @ g , and ritonavir @ g once daily ) or a standard triple-drug cART regimen ( tenofovir disoproxil fumarate @ g plus emtricitabine @ g , darunavir @ g , and ritonavir @ g once daily ) using a predefined randomised list generated by randomly selected variable block sizes .